Literature DB >> 31355233

Acupuncture therapy for essential hypertension: a network meta-analysis.

Xiaodong Tan1,2, Yujing Pan1, Wei Su2, Shaoyu Gong2, Hongjun Zhu2, Hao Chen1, Shu Lu2.   

Abstract

BACKGROUND: To evaluate the efficacy and safety of acupuncture therapies for the treatment of essential hypertension.
METHODS: We performed a systematic electronic search of PubMed, Embase, the Cochrane Library, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), and Wan-fang Data Database. The main outcome indicators measured were the amount of major adverse cardiovascular events (MACE), a change of blood pressure, and the response rate. STATA15.0 software was used for the network meta-analysis.
RESULTS: A total of 31 trials with 2,649 patients were included. Patients were allocated to 15 kinds of interventions. These including acupuncture types were electroacupuncture, moxibustion, warm needle therapy, sham acupuncture, behavioral therapy, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blocker (CCB), beta-blocker, acupuncture combined ACEI, acupuncture combined CCB, acupuncture combined behavior, electroacupuncture combined CCB, and non-treatment. The results of the network meta-analysis showed that there was no significant clinical or statistic difference in systolic blood pressure (SBP) change magnitude between acupuncture treatment and the other 14 therapies. Moxibustion may be better than acupuncture in reducing diastolic blood pressure (DBP) [mean difference (MD): 15.9, 95% confidence interval (CI): 5.96-25.85]. There was no significant difference in reducing DBP between acupuncture and the other 13 interventions. The effective rate of acupuncture combined with AECI [odds ratio (OR) =7.96, 95% CI: 1.11-56.92] and acupuncture combined with behavioral therapy (OR =3.53, 95% CI: 1.08-11.51) in treating hypertension was better than that of acupuncture alone, and there was no statistically significant difference in the effective rate between acupuncture and the other therapies.
CONCLUSIONS: The existing evidence shows that acupuncture could be used for treating hypertension, and it may have the same effects as common medication. However, due to the low qualities of the original studies, the quality of this evidence is poor. Therefore, it is recommended that more scientific research be performed to confirm the efficacy of acupuncture.

Entities:  

Keywords:  Acupuncture; hypertension; network meta-analysis

Year:  2019        PMID: 31355233      PMCID: PMC6614319          DOI: 10.21037/atm.2019.05.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  23 in total

1.  Better reporting of harms in randomized trials: an extension of the CONSORT statement.

Authors:  John P A Ioannidis; Stephen J W Evans; Peter C Gøtzsche; Robert T O'Neill; Douglas G Altman; Kenneth Schulz; David Moher
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

2.  Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects.

Authors:  Sheng-Teng Huang; Gau-Yang Chen; Huey-Ming Lo; Jaung-Gang Lin; Yin-Shiung Lee; Cheng-Deng Kuo
Journal:  Am J Chin Med       Date:  2005       Impact factor: 4.667

3.  Stop Hypertension with the Acupuncture Research Program (SHARP): results of a randomized, controlled clinical trial.

Authors:  Eric A Macklin; Peter M Wayne; Leslie A Kalish; Peter Valaskatgis; James Thompson; May C M Pian-Smith; Qunhao Zhang; Stephanie Stevens; Christine Goertz; Ronald J Prineas; Beverly Buczynski; Randall M Zusman
Journal:  Hypertension       Date:  2006-10-02       Impact factor: 10.190

4.  Acupuncture, a promising adjunctive therapy for essential hypertension: a double-blind, randomized, controlled trial.

Authors:  Changshik Yin; Byungkwan Seo; Hi-Joon Park; Miran Cho; Woosang Jung; Ryowon Choue; Changhwan Kim; Hun-Kuk Park; Hyejung Lee; Hyeonggyun Koh
Journal:  Neurol Res       Date:  2007       Impact factor: 2.448

5.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  [Clinical observation on acupuncture for treatment of hypertension of phlegm-stasis blocking collateral type].

Authors:  Fan Huang; Guo-xin Yao; Xiao-li Huang; Ying-na Liu
Journal:  Zhongguo Zhen Jiu       Date:  2007-06

8.  [Clinical observation on therapeutic effect of electroacupuncture at Quchi (LI 11) for treatment of essential hypertension].

Authors:  Wen-jun Wan; Chao-yang Ma; Xiu-an Xiong; Li Wang; Lin Ding; Yi-xian Zhang; Ying Wang
Journal:  Zhongguo Zhen Jiu       Date:  2009-05

9.  Randomized trial of acupuncture to lower blood pressure.

Authors:  Frank A Flachskampf; Joachim Gallasch; Olaf Gefeller; Junxue Gan; Juntong Mao; Annette B Pfahlberg; Alois Wortmann; Lutz Klinghammer; Wolfgang Pflederer; Werner G Daniel
Journal:  Circulation       Date:  2007-06-04       Impact factor: 29.690

10.  Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.

Authors:  Hugh MacPherson; Douglas G Altman; Richard Hammerschlag; Youping Li; Taixiang Wu; Adrian White; David Moher
Journal:  Acupunct Med       Date:  2010-06-08       Impact factor: 2.267

View more
  7 in total

1.  Electroacupuncture Attenuated Phenotype Transformation of Vascular Smooth Muscle Cells via PI3K/Akt and MAPK Signaling Pathways in Spontaneous Hypertensive Rats.

Authors:  Xin-Yu Chen; Lu-Ping Yang; Ya-Ling Zheng; Yu-Xi Li; Dong-Ling Zhong; Rong-Jiang Jin; Juan Li
Journal:  Chin J Integr Med       Date:  2021-11-28       Impact factor: 1.978

2.  Improvement of intestinal flora: accompany with the antihypertensive effect of electroacupuncture on stage 1 hypertension.

Authors:  Jun-Meng Wang; Ming-Xiao Yang; Qiao-Feng Wu; Ji Chen; Shu-Fang Deng; Lin Chen; Da-Neng Wei; Fan-Rong Liang
Journal:  Chin Med       Date:  2021-01-07       Impact factor: 5.455

Review 3.  The Quality of Methodological and Reporting in Network Meta-Analysis of Acupuncture and Moxibustion: A Cross-Sectional Survey.

Authors:  Ting Yuan; Jun Xiong; Xue Wang; Jun Yang; Yunfeng Jiang; Xiaohong Zhou; Kai Liao; Lingling Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-11       Impact factor: 2.629

4.  Traditional Chinese Medicine for Essential Hypertension: A Clinical Evidence Map.

Authors:  Yan Zhang; Biqing Wang; Chunxiao Ju; Lu Liu; Ying Zhu; Jun Mei; Yue Liu; Fengqin Xu
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-18       Impact factor: 2.629

5.  Acupuncture against the metabolic risk factors for stroke: A systematic review of systematic reviews.

Authors:  Ying Xu; Da-Yuan Zhong; Xiao-Qian Liao; Xing-Ping Wang; Jin-Wen Ge; Wei-Hui Xu
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

Review 6.  The application of acupuncture in cardiopathy: A bibliometric analysis based on Web of Science across ten recent years.

Authors:  Xiao Li; Zihan Yin; Fayang Ling; Qianhua Zheng; Xiang Li; Wenchuan Qi; Fanrong Liang
Journal:  Front Cardiovasc Med       Date:  2022-09-06

7.  Heat-sensitive moxibustion self-administration in patients in the community with primary hypertension: A protocol for a multi-center, pragmatic, non-randomized trial.

Authors:  Xu Zhou; Qingni Wu; Gaochuan Zhang; Yanping Wang; Shuqing Li; Baiyang Wang; Zhihua Chen; Weifeng Zhu; Fei Wang; Chun Gan
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.